Systematic determination of telomerase activity and telomerase length during the progression of human breast cancer in cell culture models - PubMed (original) (raw)
. 1997 Nov-Dec;17(6D):4435-41.
Affiliations
- PMID: 9494546
Systematic determination of telomerase activity and telomerase length during the progression of human breast cancer in cell culture models
S A Imam et al. Anticancer Res. 1997 Nov-Dec.
Abstract
The purpose of the study was to determine systematically the expression of telomerase activity and the length of telomere repeat arrays by utilizing two different cell culture models that derive from normal individual donors, and probably represent various stages of human breast oncogenesis in cell culture. The models consist of mortal, non-tumorigenic immortal and tumorigenic immortal human mammary epithelial cell (MEC) lines. Using a recently developed polymerase chain reaction (PCR)-based telomeric repeat amplification protocol (TRAP) assay, telomerase activity was undetectable in mortal MEC cells. In contrast, the immortal MEC that were nontumorigenic or tumorigenic in immunosuppressed athymic mice, showed telomerase activity. The absence of telomerase activity in mortal and its presence in both non-tumorigenic and tumorigenic immortal cell lines did not reflect their proliferative rate, as demonstrated by the similar pattern and intensity of reactivity of these cell lines with anti-Ki 67 antibody which recognizes a human nuclear cell proliferation--associated antigen. Southern blot analyses of Hinf I-digested genomic DNA hybridized with a (TTAGGG)4 probe revealed arrays of telomeric repeat lengths ranging from 3 to 5, 3.5 to 9, 3.2 to 9 or 3 to 15 kilobase pair (kbp) for mortal, nontumorigenic immortal, and tumorigenic immortal or established MEC lines respectively. These results suggest that telomerase activity and stable telomeric repeat lengths may be a molecular phenotype of the early stages in the progression of breast cancer.
Similar articles
- Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I, Cohen-Barak O, Shachaf C, Ravel Y, Yalon-Hacohen M, Mills GB, Tzukerman M, Skorecki KL. Braunstein I, et al. Cancer Res. 2001 Jul 15;61(14):5529-36. Cancer Res. 2001. PMID: 11454703 - Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
Yang G, Rosen DG, Mercado-Uribe I, Colacino JA, Mills GB, Bast RC Jr, Zhou C, Liu J. Yang G, et al. Carcinogenesis. 2007 Jan;28(1):174-82. doi: 10.1093/carcin/bgl115. Epub 2006 Jul 8. Carcinogenesis. 2007. PMID: 16829690 - Human models of breast cancer.
Taylor-Papadimitriou J, Berdichevsky F, D'Souza B, Burchell J. Taylor-Papadimitriou J, et al. Cancer Surv. 1993;16:59-78. Cancer Surv. 1993. PMID: 8348539 Review. - Human breast carcinoma cells in continuous culture: a review.
Engel LW, Young NA. Engel LW, et al. Cancer Res. 1978 Nov;38(11 Pt 2):4327-39. Cancer Res. 1978. PMID: 212193 Review.
Cited by
- Telomeres and telomerase in endocrine pathology.
Kontogeorgos G, Kovacs K. Kontogeorgos G, et al. Endocrine. 1998 Oct;9(2):133-8. doi: 10.1385/ENDO:9:2:133. Endocrine. 1998. PMID: 9867246 Review. - Breast cancer cell lines: friend or foe?
Burdall SE, Hanby AM, Lansdown MR, Speirs V. Burdall SE, et al. Breast Cancer Res. 2003;5(2):89-95. doi: 10.1186/bcr577. Epub 2003 Feb 3. Breast Cancer Res. 2003. PMID: 12631387 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical